Crinetics Pharmaceuticals (CRNX) Current Leases (2021 - 2025)
Historic Current Leases for Crinetics Pharmaceuticals (CRNX) over the last 5 years, with Q3 2025 value amounting to $6.4 million.
- Crinetics Pharmaceuticals' Current Leases fell 1311.21% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 1311.21%. This contributed to the annual value of $7.2 million for FY2024, which is 7138.75% up from last year.
- Crinetics Pharmaceuticals' Current Leases amounted to $6.4 million in Q3 2025, which was down 1311.21% from $6.6 million recorded in Q2 2025.
- Crinetics Pharmaceuticals' 5-year Current Leases high stood at $7.4 million for Q2 2024, and its period low was $939000.0 during Q4 2021.
- Its 5-year average for Current Leases is $4.4 million, with a median of $5.0 million in 2023.
- Its Current Leases has fluctuated over the past 5 years, first soared by 57132.55% in 2024, then tumbled by 1311.21% in 2025.
- Crinetics Pharmaceuticals' Current Leases (Quarter) stood at $939000.0 in 2021, then grew by 11.93% to $1.1 million in 2022, then soared by 297.05% to $4.2 million in 2023, then skyrocketed by 71.39% to $7.2 million in 2024, then dropped by 9.94% to $6.4 million in 2025.
- Its Current Leases stands at $6.4 million for Q3 2025, versus $6.6 million for Q2 2025 and $6.9 million for Q1 2025.